Moleculin Biotech, Inc
Moleculin Biotech, Inc, based in Houston, TX, is a cutting-edge biotechnology company focused on advancing a diverse pipeline of product candidates for the treatment of highly resistant cancers and viruses. Utilizing proprietary technologies and data, Moleculin is dedicated to developing innovative therapies, including a next-generation anthracycline, immune transcription modulators, STAT3 inhibitors, and metabolism glycosylation inhibitors.
The company's priority development pipeline showcases their commitment to pioneering better treatments for challenging medical conditions, with a strong emphasis on delivering impactful solutions for patients facing complex diseases such as soft tissue sarcomas, acute myeloid leukemia, and other critical health challenges.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.

